 ASI Biont: How AI-Biointegration Becomes a New Frontier for Major Investors The crypto investment market in 2026 takes an unexpected turn — capital is moving away from speculative memecoins toward projects with real infrastructure. And at the intersection of two megatrends — AGI and biointegration — a new asset class is forming. Why this matters for investors from $1M: 1. Growing interest in AI-biointegration — according to recent quarters, venture funds have increased their share in AI-biotech by 40%+. Projects where AI agents work with biological data receive premium valuations. 2. ASI Biont — a platform where anyone can launch their own AI agent without code or skills. From market analytics to business process automation. Agents learn, adapt, and work 24/7. 3. Implementation cases already show: businesses with up to 50 employees save from 20 hours per week on routine tasks. Entrepreneurs shift focus to strategy, while agents handle operations. What we offer major investors: — Transparent model: each agent is an asset with measurable efficiency. — Tokens at launch (1500) for new users — entry without barriers. — Scaling: from one agent to an entire staff of AI employees. The market is changing. Those who enter the infrastructure at an early stage shape the rules of the game. Join the webinar for major investors — we'll break down growth metrics, case studies, and the ASI Biont roadmap for 2026-2027. [https://asibiont.com/](https://asibiont.com/) #ASI Biont #AI #investments #biointegration #cryptotrends #agents